Objective Thirteen human papillomavirus (HPV) genotypes are associated with the highest
risk of cervical disease/cancer; however, the risk of disease progression and cancer is …

Objectives The baseline phase of the Onclarity trial was conducted to determine the
screening performance of the Onclarity human papillomavirus (HPV) assay for detecting …

Background: Human papillomavirus (HPV) testing provides a much more sensitive method
of detection for high-grade lesions than cytology, but specificity is low. Here, we explore the …

OBJECTIVE: This is a meta-analysis of studies comparing HPV testing to cytology with
regard to their accuracy in the detection of underlying high grade cervical intraepithelial …

Genotyping may improve risk stratification of high‐risk (HR) human papillomavirus (HPV)‐
positive women in cervical screening programs; however, prospective data comparing the …

The Canadian Cervical Cancer Screening Trial was a randomized controlled trial comparing
the performance of human papillomavirus (HPV) testing and Papanicolaou cytology to …

Background HPV16/18 detection may improve cervical cancer risk stratification and better
guide which HPV-positive women warrant immediate colposcopy/biopsy. We estimated risks …

Objective We assessed the age-related prevalence of high risk human papillomavirus (HR-
HPV) genotypes and the genotype-associated risk for high-grade cervical intraepithelial …

Objectives Increasing evidence suggests that extended human papillomavirus (HPV)
genotyping (beyond 16/18) is effective for risk stratification in women with normal cytology …

Cervical cytology screening has reduced cervical cancer morbidity and mortality but shows
important shortcomings in terms of sensitivity and specificity. Infection with distinct types of …